Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 28, 2017 07:00 ET | Source: Trico Charitable Foundation

Showcasing Canada’s Amazing Social Entrepreneurs: Applications Open for the $100,000 Social EnterPrize

CALGARY, Alberta, Feb. 28, 2017 (GLOBE NEWSWIRE) -- Created by the Trico Charitable Foundation in 2011, the biennial Social EnterPrize celebrates and advances leadership and excellence in social...
February 28, 2017 07:00 ET | Source: Platform Specialty Products Corporation

Platform Specialty Products Corporation Announces 2016 Fourth Quarter and Full Year Financial Performance

2016 net sales of $3.6 billion, an increase of 41.0%; record net sales of $950 million in Q4 2016FY and Q4 2016 organic sales increase of 2.0% and 4.6%, respectively2016 GAAP basic EPS loss of $0.14...
February 28, 2017 07:00 ET | Source: XOMA Corporation

XOMA to Present New Strategic Initiatives at the Cowen and Company 37th Annual Health Care Conference

BERKELEY, Calif., Feb. 28, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today that Jim Neal, Chief...
February 28, 2017 07:00 ET | Source: Actinium Pharmaceuticals

Actinium Announces Expansion of Intellectual Property Portfolio with Notice of Allowance for U.S. Patent Related to Actimab-A, Actimab-M and the Company’s Technology Platform

Allowed patent application claims methods for generating radioimmunoconjugates linked to Actinium-225 Patent expected to expire in July 2030 NEW YORK, Feb. 28, 2017 (GLOBE NEWSWIRE) --...
February 28, 2017 07:00 ET | Source: PRGX Global, Inc.

PRGX Global, Inc. Announces Fourth Quarter and Full Year 2016 Financial Results

ATLANTA, Feb. 28, 2017 (GLOBE NEWSWIRE) -- PRGX Global, Inc. (Nasdaq:PRGX), a global leader in Recovery Audit and Spend Analytics services, today announced its unaudited financial results for the...
February 28, 2017 07:00 ET | Source: Miragen Therapeutics, Inc.

miRagen Therapeutics to Participate in Two Investor Conferences in March

BOULDER, Colo., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Miragen Therapeutics, Inc. (Nasdaq:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA-targeted...
February 28, 2017 07:00 ET | Source: Coates International

Coates International, Ltd. Has an Agreement in Place With Secure Supplies USA LLC and Secure Supplies Mexico LLC – Initial Orders Will be for a Project in New Jersey That Will Require 35, 1MW CSRV Hydrogen Powered Industrial Gen Sets and a Project in Mexico That Will Require 40, 1 MW CSRV Hydrogen Powered Industrial Gen Sets - Estimated Value of These Projects is $35,000,000 in New Jersey and $40,000,000 in Mexico for a Total Value to Coates of $75,000,000

WALL TOWNSHIP, N.J., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Coates International, Ltd. (OTC PINK:COTE) (the “Company”) has previously entered into a sublicense agreement with Secure Supplies USA LLC and...
February 28, 2017 07:00 ET | Source: REGENXBIO Inc.

REGENXBIO to Host Conference Call on March 7 to Discuss Fourth Quarter and Full-Year 2016 Financial Results and Recent Operational Highlights

ROCKVILLE, Md., Feb. 28, 2017 (GLOBE NEWSWIRE) -- REGENXBIO Inc. (Nasdaq:RGNX), a leading biotechnology company focused on the development, commercialization and licensing of recombinant...
February 28, 2017 07:00 ET | Source: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals to Present Breakthrough Therapy Designated-PTSD Program and Corporate Update at the Cowen and Company 37th Annual Health Care Conference

TNX-102 SL, a Phase 3 Drug Candidate, Recently Granted Breakthrough Therapy Designation by the US FDA Pivotal Study in Military-Related PTSD to Begin This Quarter NEW YORK, Feb. 28, 2017 (GLOBE...
February 28, 2017 07:00 ET | Source: Antares Pharma Inc

Antares Pharma to Present at the Cowen and Company 37th Annual Healthcare Conference

EWING, N.J., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Cowen and Company...

1 ...182182 182183 182184 ...323366